评估胺对重症患者血管压缩剂需求的影响:回顾性队列研究
Noah Gann1, Patrick Ratliff1, Avery Guerrero1
1CHI Saint Joseph Health, Lexington, KY, USA.
Hospital pharmacy
|October 20, 2025
概括
持续输注胺可以减少危急病患者的血管压缩剂需求. 这项研究发现,胺作为辅助镇静剂在需要血液动力学支持的机械通风患者中降低了血管压缩剂的需求.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 麻醉学 麻醉学
背景情况:
- 胺是用于手术镇静和输管治疗的镇静剂.
- 连续输注胺可以为机械通风患者提供镇静和止痛.
- 胺可以通过增加心血管功能来降低血管压缩剂的需求.
研究的目的:
- 为了调查胺作为辅助镇静剂是否会降低危急病患者的血管压缩剂需求.
- 为了评估连续胺注射对血管压缩剂需求的影响.
主要方法:
- 在社区医院进行回顾性队列研究.
- 包括接受血管压缩剂和持续胺注射的机械通风患者.
- 主要结局:在开他开始后6小时,12小时和24小时,血管压缩剂需求的变化.
主要成果:
- 41名患者符合纳入标准.
- 从基线看,胺输注后6小时,12小时和24小时的平均血管压缩剂需求显著下降.
- 在平均血管压缩剂要求中观察到统计学上显著的差异 (P=.035).
结论:
- 连续输注胺可以降低平均血管压缩剂的需求.
- 胺作为辅助镇静剂在需要血管压缩器的机械通风患者中是有效的.
更多相关视频
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
9.2K
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
14.4K
相关概念视频
Parenteral Anesthetics: Overview
574
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
574
Acute Kidney Injury IV: Diagnostic Studies and Prevention
257
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
257
Cardiopulmonary Resuscitation IV: Pharmacological Management
645
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
645
